386 related articles for article (PubMed ID: 7349726)
1. Hyposensitization (immunotherapy) in allergic diseases: an introduction.
Fuchs E
Allergol Immunopathol (Madr); 1981; Suppl 9():167-70. PubMed ID: 7349726
[No Abstract] [Full Text] [Related]
2. [Allergic desensitization: review of controlled clinical trials].
Pécoud A
Schweiz Med Wochenschr; 1985 Nov; 115(46):1651-3. PubMed ID: 3909392
[TBL] [Abstract][Full Text] [Related]
3. [Apropos of sublingual specific immunotherapy].
Sabbah A
Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
[No Abstract] [Full Text] [Related]
4. [Basis of specific desensitization].
Vervloet D
Allergol Immunopathol (Madr); 1981; Suppl 9():163-6. PubMed ID: 7349725
[No Abstract] [Full Text] [Related]
5. [Specific immunotherapy--past--present--future].
Kägi MK
Praxis (Bern 1994); 1998 Sep; 87(40):1330-4. PubMed ID: 9816927
[TBL] [Abstract][Full Text] [Related]
6. [Hyposensitization treatment of allergic diseases].
Wüthrich B
Schweiz Rundsch Med Prax; 1993 May; 82(18):529-33. PubMed ID: 8497762
[TBL] [Abstract][Full Text] [Related]
7. [Practical problems in specific hyposensitization].
Oehling A
Med Klin; 1972 Jul; 67(29):983-8. PubMed ID: 5051382
[No Abstract] [Full Text] [Related]
8. [Possibilities and limitations of desensitization].
Wenz W
Z Gesamte Inn Med; 1980 Jan; 35(2):91-8. PubMed ID: 6996356
[TBL] [Abstract][Full Text] [Related]
9. [Practice of hyposensitization in allergic diseases].
Wüthrich B
Schweiz Rundsch Med Prax; 1993 May; 82(18):534-9. PubMed ID: 8497763
[TBL] [Abstract][Full Text] [Related]
10. [Specific hyposensitization using pyridine extracts precipitated with aluminum. III. Intolerance to the extracts. Anatomo-pathological study of the receptor area].
Basomba A; Tamarit L; Peláez A; Villalmanzo IG
Allergol Immunopathol (Madr); 1974; 2(5):325-32. PubMed ID: 4218447
[No Abstract] [Full Text] [Related]
11. [Sublingual vs subcutaneous immunotherapy].
Olivé Pérez A
Rev Alerg Mex; 2004; 51(1):29-35. PubMed ID: 15119753
[TBL] [Abstract][Full Text] [Related]
12. Hyposensitization in asthma: a review.
Warner JO
J R Soc Med; 1981 Jan; 74(1):60-5. PubMed ID: 7007640
[No Abstract] [Full Text] [Related]
13. [Hyposensitization in allergic diseases?].
Fuchs E
Dtsch Med Wochenschr; 1988 Jun; 113(25):1025-8. PubMed ID: 3289877
[No Abstract] [Full Text] [Related]
14. [The value of immunotherapy in treatment of IgE-induced allergic diseases].
Müller UR
Ther Umsch; 1994 Jan; 51(1):67-76. PubMed ID: 7511841
[TBL] [Abstract][Full Text] [Related]
15. [Specific hyposensitizing therapy. Considerations on its effectiveness and validity].
Gallesio MT; Furno F
Minerva Med; 1979 Apr; 70(18):1299-303. PubMed ID: 450269
[TBL] [Abstract][Full Text] [Related]
16. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
[TBL] [Abstract][Full Text] [Related]
17. [Respiratory hypersensitivity to house dust mites: therapeutic value of the Bencard House Dust Unit].
Grosclaude M; Biot N; Meyer JL; Perrin-Fayolle M
Nouv Presse Med; 1978 Nov; 7(41):3777. PubMed ID: 733535
[No Abstract] [Full Text] [Related]
18. [Multicenter drug surveillance of sublingual immunotherapy in allergic patients].
Almagro E; Asensio O; Bartolomé JM; Bosque M; de la Hoz B; Dolz I; Elorza J; Ferreiro M; García JM; Losada E
Allergol Immunopathol (Madr); 1995; 23(4):153-9. PubMed ID: 8553989
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of housedustmite-allergy-three years' experience with hyposensitization with D.pteronyssinus-Preparations (D.P.) (author's transl)].
Stammberger H
Laryngol Rhinol Otol (Stuttg); 1980; 59(12):820-8. PubMed ID: 7278471
[TBL] [Abstract][Full Text] [Related]
20. [Risks of specific hyposensitization treatment].
Rakoski J
Z Hautkr; 1988; 63 Suppl 4():26-30. PubMed ID: 3075381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
